Capsaicin and nociception: from basic mechanisms to novel drugs
- 1 September 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 356 (9232) , 785-787
- https://doi.org/10.1016/s0140-6736(00)02649-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Activation of the somatosensory cortex during Aβ-fiber mediated hyperalgesia: a MSI studyBrain Research, 2000
- Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesiaNature, 2000
- Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin ReceptorScience, 2000
- Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and humanProceedings of the National Academy of Sciences, 2000
- Postherpetic Neuralgia: Irritable Nociceptors and DeafferentationNeurobiology of Disease, 1998
- Treatment of Intractable Pain with Topical Large-Dose CapsaicinAnesthesia & Analgesia, 1998
- Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjectsPain, 1995
- The postmastectomy pain syndrome and topical capsaicin: a randomized trialPain, 1992
- Dynamic and static components of mechanical hyperalgesia in human hairy skinPain, 1992
- Treatment of Painful Diabetic Neuropathy With Topical CapsaicinArchives of internal medicine (1960), 1991